Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier advances from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the previous full content and navigation with a minimal header. Users can no longer view the study details and related links on this page.SummaryDifference17%

- Check32 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the study page, representing a minor update to the record without altering study content. This reflects a backend update to the page rather than a change to participant information.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision was updated to v3.6.6, reflecting a CMS/software maintenance update rather than a change to study data or visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers, recording an additional funding attribution for the trial.SummaryDifference0.0%

- Check67 days agoChange DetectedA new revision label v3.6.5 was added, replacing the previous v3.6.4.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.